Cargando…

Clinical and Molecular Heterogeneity of RTEL1 Deficiency

Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Speckmann, Carsten, Sahoo, Sushree Sangita, Rizzi, Marta, Hirabayashi, Shinsuke, Karow, Axel, Serwas, Nina Kathrin, Hoemberg, Marc, Damatova, Natalja, Schindler, Detlev, Vannier, Jean-Baptiste, Boulton, Simon J., Pannicke, Ulrich, Göhring, Gudrun, Thomay, Kathrin, Verdu-Amoros, J. J., Hauch, Holger, Woessmann, Wilhelm, Escherich, Gabriele, Laack, Eckart, Rindle, Liliana, Seidl, Maximilian, Rensing-Ehl, Anne, Lausch, Ekkehart, Jandrasits, Christine, Strahm, Brigitte, Schwarz, Klaus, Ehl, Stephan R., Niemeyer, Charlotte, Boztug, Kaan, Wlodarski, Marcin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410638/
https://www.ncbi.nlm.nih.gov/pubmed/28507545
http://dx.doi.org/10.3389/fimmu.2017.00449
_version_ 1783232723521896448
author Speckmann, Carsten
Sahoo, Sushree Sangita
Rizzi, Marta
Hirabayashi, Shinsuke
Karow, Axel
Serwas, Nina Kathrin
Hoemberg, Marc
Damatova, Natalja
Schindler, Detlev
Vannier, Jean-Baptiste
Boulton, Simon J.
Pannicke, Ulrich
Göhring, Gudrun
Thomay, Kathrin
Verdu-Amoros, J. J.
Hauch, Holger
Woessmann, Wilhelm
Escherich, Gabriele
Laack, Eckart
Rindle, Liliana
Seidl, Maximilian
Rensing-Ehl, Anne
Lausch, Ekkehart
Jandrasits, Christine
Strahm, Brigitte
Schwarz, Klaus
Ehl, Stephan R.
Niemeyer, Charlotte
Boztug, Kaan
Wlodarski, Marcin W.
author_facet Speckmann, Carsten
Sahoo, Sushree Sangita
Rizzi, Marta
Hirabayashi, Shinsuke
Karow, Axel
Serwas, Nina Kathrin
Hoemberg, Marc
Damatova, Natalja
Schindler, Detlev
Vannier, Jean-Baptiste
Boulton, Simon J.
Pannicke, Ulrich
Göhring, Gudrun
Thomay, Kathrin
Verdu-Amoros, J. J.
Hauch, Holger
Woessmann, Wilhelm
Escherich, Gabriele
Laack, Eckart
Rindle, Liliana
Seidl, Maximilian
Rensing-Ehl, Anne
Lausch, Ekkehart
Jandrasits, Christine
Strahm, Brigitte
Schwarz, Klaus
Ehl, Stephan R.
Niemeyer, Charlotte
Boztug, Kaan
Wlodarski, Marcin W.
author_sort Speckmann, Carsten
collection PubMed
description Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recently been described as a major genetic etiology, but the molecular basis and clinical consequences of RTEL1-associated DC are incompletely characterized. We report our observations in a cohort of six patients: five with novel biallelic RTEL1 mutations p.Trp456Cys, p.Ile425Thr, p.Cys1244ProfsX17, p.Pro884_Gln885ins53X13, and one with novel heterozygous mutation p.Val796AlafsX4. The most unifying features were hypocellular BMF in 6/6 and B-/NK-cell lymphopenia in 5/6 patients. In addition, three patients with homozygous mutations p.Trp456Cys or p.Ile425Thr also suffered from immunodeficiency, cerebellar hypoplasia, and enteropathy, consistent with Hoyeraal-Hreidarsson syndrome. Chromosomal breakage resembling a homologous recombination defect was detected in patient-derived fibroblasts but not in hematopoietic compartment. Notably, in both cellular compartments, differential expression of 1243aa and 1219/1300aa RTEL1 isoforms was observed. In fibroblasts, response to ionizing irradiation and non-homologous end joining were not impaired. Telomeric circles did not accumulate in patient-derived primary cells and lymphoblastoid cell lines, implying alternative pathomechanisms for telomeric loss. Overall, RTEL1-deficient cells exhibited a phenotype of replicative exhaustion, spontaneous apoptosis and senescence. Specifically, CD34(+) cells failed to expand in vitro, B-cell development was compromised, and T-cells did not proliferate in long-term culture. Finally, we report on the natural history and outcome of our patients. While two patients died from infections, hematopoietic stem cell transplantation (HSCT) resulted in sustained engraftment in two patients. Whether chemotherapy negatively impacts on the course and onset of other DC-related symptoms remains open at present. Early-onset lung disease occurred in one of our patients after HSCT. In conclusion, RTEL deficiency can show a heterogeneous clinical picture ranging from mild hypocellular BMF with B/NK cell lymphopenia to early-onset, very severe, and rapidly progressing cellular deficiency.
format Online
Article
Text
id pubmed-5410638
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54106382017-05-15 Clinical and Molecular Heterogeneity of RTEL1 Deficiency Speckmann, Carsten Sahoo, Sushree Sangita Rizzi, Marta Hirabayashi, Shinsuke Karow, Axel Serwas, Nina Kathrin Hoemberg, Marc Damatova, Natalja Schindler, Detlev Vannier, Jean-Baptiste Boulton, Simon J. Pannicke, Ulrich Göhring, Gudrun Thomay, Kathrin Verdu-Amoros, J. J. Hauch, Holger Woessmann, Wilhelm Escherich, Gabriele Laack, Eckart Rindle, Liliana Seidl, Maximilian Rensing-Ehl, Anne Lausch, Ekkehart Jandrasits, Christine Strahm, Brigitte Schwarz, Klaus Ehl, Stephan R. Niemeyer, Charlotte Boztug, Kaan Wlodarski, Marcin W. Front Immunol Immunology Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recently been described as a major genetic etiology, but the molecular basis and clinical consequences of RTEL1-associated DC are incompletely characterized. We report our observations in a cohort of six patients: five with novel biallelic RTEL1 mutations p.Trp456Cys, p.Ile425Thr, p.Cys1244ProfsX17, p.Pro884_Gln885ins53X13, and one with novel heterozygous mutation p.Val796AlafsX4. The most unifying features were hypocellular BMF in 6/6 and B-/NK-cell lymphopenia in 5/6 patients. In addition, three patients with homozygous mutations p.Trp456Cys or p.Ile425Thr also suffered from immunodeficiency, cerebellar hypoplasia, and enteropathy, consistent with Hoyeraal-Hreidarsson syndrome. Chromosomal breakage resembling a homologous recombination defect was detected in patient-derived fibroblasts but not in hematopoietic compartment. Notably, in both cellular compartments, differential expression of 1243aa and 1219/1300aa RTEL1 isoforms was observed. In fibroblasts, response to ionizing irradiation and non-homologous end joining were not impaired. Telomeric circles did not accumulate in patient-derived primary cells and lymphoblastoid cell lines, implying alternative pathomechanisms for telomeric loss. Overall, RTEL1-deficient cells exhibited a phenotype of replicative exhaustion, spontaneous apoptosis and senescence. Specifically, CD34(+) cells failed to expand in vitro, B-cell development was compromised, and T-cells did not proliferate in long-term culture. Finally, we report on the natural history and outcome of our patients. While two patients died from infections, hematopoietic stem cell transplantation (HSCT) resulted in sustained engraftment in two patients. Whether chemotherapy negatively impacts on the course and onset of other DC-related symptoms remains open at present. Early-onset lung disease occurred in one of our patients after HSCT. In conclusion, RTEL deficiency can show a heterogeneous clinical picture ranging from mild hypocellular BMF with B/NK cell lymphopenia to early-onset, very severe, and rapidly progressing cellular deficiency. Frontiers Media S.A. 2017-05-01 /pmc/articles/PMC5410638/ /pubmed/28507545 http://dx.doi.org/10.3389/fimmu.2017.00449 Text en Copyright © 2017 Speckmann, Sahoo, Rizzi, Hirabayashi, Karow, Serwas, Hoemberg, Damatova, Schindler, Vannier, Boulton, Pannicke, Göhring, Thomay, Verdu-Amoros, Hauch, Woessmann, Escherich, Laack, Rindle, Seidl, Rensing-Ehl, Lausch, Jandrasits, Strahm, Schwarz, Ehl, Niemeyer, Boztug and Wlodarski. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Speckmann, Carsten
Sahoo, Sushree Sangita
Rizzi, Marta
Hirabayashi, Shinsuke
Karow, Axel
Serwas, Nina Kathrin
Hoemberg, Marc
Damatova, Natalja
Schindler, Detlev
Vannier, Jean-Baptiste
Boulton, Simon J.
Pannicke, Ulrich
Göhring, Gudrun
Thomay, Kathrin
Verdu-Amoros, J. J.
Hauch, Holger
Woessmann, Wilhelm
Escherich, Gabriele
Laack, Eckart
Rindle, Liliana
Seidl, Maximilian
Rensing-Ehl, Anne
Lausch, Ekkehart
Jandrasits, Christine
Strahm, Brigitte
Schwarz, Klaus
Ehl, Stephan R.
Niemeyer, Charlotte
Boztug, Kaan
Wlodarski, Marcin W.
Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title_full Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title_fullStr Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title_full_unstemmed Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title_short Clinical and Molecular Heterogeneity of RTEL1 Deficiency
title_sort clinical and molecular heterogeneity of rtel1 deficiency
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410638/
https://www.ncbi.nlm.nih.gov/pubmed/28507545
http://dx.doi.org/10.3389/fimmu.2017.00449
work_keys_str_mv AT speckmanncarsten clinicalandmolecularheterogeneityofrtel1deficiency
AT sahoosushreesangita clinicalandmolecularheterogeneityofrtel1deficiency
AT rizzimarta clinicalandmolecularheterogeneityofrtel1deficiency
AT hirabayashishinsuke clinicalandmolecularheterogeneityofrtel1deficiency
AT karowaxel clinicalandmolecularheterogeneityofrtel1deficiency
AT serwasninakathrin clinicalandmolecularheterogeneityofrtel1deficiency
AT hoembergmarc clinicalandmolecularheterogeneityofrtel1deficiency
AT damatovanatalja clinicalandmolecularheterogeneityofrtel1deficiency
AT schindlerdetlev clinicalandmolecularheterogeneityofrtel1deficiency
AT vannierjeanbaptiste clinicalandmolecularheterogeneityofrtel1deficiency
AT boultonsimonj clinicalandmolecularheterogeneityofrtel1deficiency
AT pannickeulrich clinicalandmolecularheterogeneityofrtel1deficiency
AT gohringgudrun clinicalandmolecularheterogeneityofrtel1deficiency
AT thomaykathrin clinicalandmolecularheterogeneityofrtel1deficiency
AT verduamorosjj clinicalandmolecularheterogeneityofrtel1deficiency
AT hauchholger clinicalandmolecularheterogeneityofrtel1deficiency
AT woessmannwilhelm clinicalandmolecularheterogeneityofrtel1deficiency
AT escherichgabriele clinicalandmolecularheterogeneityofrtel1deficiency
AT laackeckart clinicalandmolecularheterogeneityofrtel1deficiency
AT rindleliliana clinicalandmolecularheterogeneityofrtel1deficiency
AT seidlmaximilian clinicalandmolecularheterogeneityofrtel1deficiency
AT rensingehlanne clinicalandmolecularheterogeneityofrtel1deficiency
AT lauschekkehart clinicalandmolecularheterogeneityofrtel1deficiency
AT jandrasitschristine clinicalandmolecularheterogeneityofrtel1deficiency
AT strahmbrigitte clinicalandmolecularheterogeneityofrtel1deficiency
AT schwarzklaus clinicalandmolecularheterogeneityofrtel1deficiency
AT ehlstephanr clinicalandmolecularheterogeneityofrtel1deficiency
AT niemeyercharlotte clinicalandmolecularheterogeneityofrtel1deficiency
AT boztugkaan clinicalandmolecularheterogeneityofrtel1deficiency
AT wlodarskimarcinw clinicalandmolecularheterogeneityofrtel1deficiency